Latest Announcements

Amber Enterprises India Limited has informed the Exchange about Investor Presentation for Q1FY27 results, highlighting key business highlights, including a manufacturing collaboration agreement with Oppo Mobiles India Private Limited and the ground-breaking ceremony for the HDI PCB Manufacturing Facility.

Amber Enterprises India Ltd has announced its unaudited financial results for Q1FY27, with revenue from operations at ₹3,888 Cr, operating EBITDA at ₹3,449 Cr, and adjusted PAT at ₹337 Cr. The company has also entered into a manufacturing collaboration agreement with Oppo Mobiles India Private Limited, covering smartphones brands OPPO, OnePlus, and Realme.

Amber Enterprises India Limited has declared its unaudited financial results for the quarter ended 30th June 2026, with revenue from operations of ₹3,888 Cr, growth of 13% over the same quarter of the previous year. The company's operating EBITDA grew by 28% and adjusted PAT grew by 19%.

Amber Enterprises India Ltd has announced its unaudited financial results for Q1 FY27, with revenue from operations at ₹3,888 Cr, a 13% growth over the same quarter of the previous year. The company's operating EBITDA was ₹337 Cr, a 28% growth over the same quarter of the previous year, and adjusted PAT was ₹126 Cr, a 19% growth over the same quarter of the previous year. The company has also announced a manufacturing collaboration with OPPO Mobiles India Private Limited and expansion plans for its Ascent-K Circuit's facility.

HMA Agro Industries Ltd has released its Q1 FY 2026-2027 results, showing significant revenue growth of 87.97% and 90.37% year-over-year and quarter-over-quarter respectively. The company's revenue for Q1 FY 2026-2027 was ₹21,103.19 million, with an EBITDA of ₹552.81 million and a PAT of ₹319.11 million.

HMA Agro Industries Limited has released its Q1 FY 2026-2027 investor presentation, showing significant revenue growth of 87.97% and 90.37% year-over-year and quarter-over-quarter respectively. The company's revenue for Q1 FY 2026-2027 was ₹21,103.19 million, compared to ₹11,226.10 million in Q1 FY 2025-2026.

HMA Agro Industries Ltd has released its Q1 FY 2026-2027 investor presentation, showing significant growth in revenue and EBITDA. The company's revenue increased by 87.97% and 90.37% compared to Q1 FY 2025-2026, respectively. EBITDA also saw a significant increase of 44.02% and 208.73% compared to Q1 FY 2025-2026, respectively. The company's market price has increased to ₹22.01, and the market capitalization stands at ₹1102.20Cr.

HMA Agro Industries Limited has announced its Q1 FY 2026-2027 results, showing significant revenue growth of 87.97% and 90.37% year-over-year and quarter-over-quarter respectively. The company's revenue for Q1 FY 2026-2027 stood at ₹21,103.19 million and ₹20,721.36 million.

Delhivery Ltd reported Q1FY27 unaudited financial results, with revenues of Rs.3000 Cr, up 28% YoY, and EBITDA of Rs.156 Cr, a 5% growth YoY. Despite a challenging external environment, the company delivered record volumes, with its express business delivering 322 million packages in Q1, a 55% YoY growth. The company's PTL network also grew, with freight delivery of 542,000 tonnes, a 18% YoY growth. The company's supply chain services business generated Rs.200 Cr of revenue in Q1.

Delhivery Limited has informed the exchange about the transcript of earnings conference call pertaining to the unaudited financial results for the quarter ended June 30, 2026. The company reported a 28% year-on-year growth in revenues and a 5% growth in EBITDA. Despite a challenging external environment, Delhivery delivered record volumes in Q1, with its express business delivering 322 million packages, a 55% year-on-year growth.

Krsnaa Diagnostics Limited has announced its Q1 FY2027 results, with revenue growing 22% YoY to ₹2,355 million, and the Rajasthan pathology network transitioning from implementation to operations, contributing ₹257 million of revenue in Q1. The company has also approved the issue of share warrants to the Promoter and Promoter Group, subject to applicable approvals and regulatory requirements.

Krsnaa Diagnostics Ltd announced its unaudited financial results for Q1 FY2027, with revenue from operations growing 22% YoY to ₹2,355 million, and the Rajasthan pathology network transitioning from implementation to operations.

Ola Electric Mobility Ltd submitted the transcript of the earnings conference call held on August 7, 2026, with the exchange, detailing Q1 FY27 results, including growth in deliveries, orders, and auto revenue, and a decline in operating expenses.

Ola Electric Mobility Limited has announced its Q1 FY27 earnings, with revenue growth of 72% sequentially to ₹455 crore, gross profit of ₹139 crore, and a market share increase from 5.1% to 8.4%. The company has also completed a ₹780 crore QIP, strengthening its balance sheet.

Galaxy Surfactants Limited announced its unaudited financial results for the quarter ended June 30, 2026, with record quarterly EBITDA of ₹252.5 Crore, marking strong earnings momentum in FY27. Total revenue, EBITDA, and PAT grew 38.5%, 86.9%, and 108.7% YoY, respectively.

Supriya Lifescience Ltd. has reported a 31% YoY revenue growth in Q1 FY27, with revenues standing at Rs 189.75 crore compared to Rs 145.07 crore in Q1 FY26. The company's EBITDA margin stood at 25.0%, with a PAT of Rs 24.04 crore and a PAT margin of 12.7%.

Galaxy Surfactants Limited has informed the Exchange about Investor Presentation for Unaudited Financial Results for the quarter ended June 30, 2026. The presentation highlights the company's performance, key developments, and future prospects. The company's EBITDA grew 87% YoY to ₹252 Cr, driven by disciplined pricing, a favourable product mix, operational excellence, and improved operating leverage.

Supriya Lifescience Ltd reported a 31% YoY revenue growth in Q1 FY27, with revenue of Rs 189.75 crore, and a PAT of Rs 24.04 crore. The company's EBITDA margin declined to 25.0% in Q1 FY27 from 35.6% in Q1 FY26.

Galaxy Surfactants Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, reporting a record quarterly EBITDA of ₹252.5 crore, a 86.9% YoY increase, and a PAT of ₹165.9 crore, a 108.7% YoY increase.

Galaxy Surfactants Ltd has released an investor presentation on its unaudited financial results for the quarter ended June 30, 2026, showing a 87% YoY growth in EBITDA to ₹252 Cr and EBITDA/MT improving to ₹35,458/MT. The company reported consolidated volume growth in the mid-single digits, with a balanced contribution from both Performance Surfactants and Specialty Care. India returned to double-digit volume growth after nearly two years, driven by strong demand from Tier-1 customers and the return of reformulation-related business.